MOVE.SW Overview

Company Profile

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Related stocks

NVCR

NVCR • Switzerland

NovoCure Limited

14.58 USD

1.7B USD 1Y -0.9%

MED.SW

MED.SW • Switzerland

82.4 CHF

1.24B USD 1Y -4%

EKTA-B.ST

EKTA-B.ST • Sweden

Elekta AB ser. B

54.45 SEK

2.08B USD 1Y +8%

KURN.SW

KURN.SW • Switzerland

18.35 CHF

877.11M USD 1Y -38.4%

AMBU-B.CO

AMBU-B.CO • Denmark

72.85 DKK

2.85B USD 1Y -33.6%

LIVN

LIVN • United Kingdom

76.39 USD

4.21B USD 1Y +42.2%

GN.CO

GN.CO • Denmark

GN Store Nord A/S

107.85 DKK

2.35B USD 1Y -12.4%

DRW3.DE

DRW3.DE • Germany

DRAEGERWERK VZO O.N.

116.6 EUR

2.45B USD 1Y +70.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Medical Devices

Website

https://www.medacta.com

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

31.4% p.a.

Max Drawdown (5Y)

-52.4%

Sharpe Ratio (5Y)

-0.22

Beta Factor

1.01

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -52.4% in the extended horizon.